Noxopharm Ltd has released a press release.
Nyrada IPO Offer Fully Subscribed
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Noxopharm
- Lodgement of Nyrada Inc Supplementary Prospectus
- Nyrada Inc Initial Public Offering Opens
- Positive DARRT-1 Data in Late-Stage Prostate Cancer
- Lodgement of Nyrada Inc Prospectus - Initial Public Offering
- Noxopharm Announces Appointment of Chief Commercial Officer
Later from Noxopharm
- DARRT-1 Clinical Data Webinar
- Listing of Nyrada Inc. spin-off on ASX
- Noxopharm Dec 2019 Appendix 4C
- $8.1M Financing & Re-Set of Capital Structure
- LuPIN Trial Interim Results Indicate Striking Survival Benefit
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm